| Record ID | marc_records_scriblio_net/part23.dat:100762332:1140 |
| Source | Scriblio |
| Download Link | /show-records/marc_records_scriblio_net/part23.dat:100762332:1140?format=raw |
LEADER: 01140pam 2200301 a 4500
001 93008273
003 DLC
005 19931028070102.4
008 930428s1993 ne a b 101 0 eng c
010 $a 93008273
020 $a0444899871 (alk. paper)
040 $aDNLM/DLC$cDLC$dDLC
050 00 $aRM322$b.N48 1993
060 00 $aW1 EP455KEA no.10 1993$aQV 85 N5317 1993
082 00 $a616.8/53061$220
245 00 $aNew antiepileptic drug development :$bpreclinical and clinical aspects /$cedited by Jacqueline A. French, Marc A. Dichter, Ilo E. Leppik.
260 $aAmsterdam ;$aNew York :$bElsevier,$c1993.
300 $axv, 255 p. :$bill. ;$c27 cm.
440 0 $aEpilepsy research.$pSupplement,$x0920-1211 ;$vno. 10
500 $aPapers presented at a conference held in Miami, Florida in March 1992.
504 $aIncludes bibliographical references and index.
650 0 $aAnticonvulsants$xTesting$xCongresses.
650 2 $aAnticonvulsants$xcongresses.
650 2 $aClinical Trials$xcongresses.
650 2 $aDrug Approval$xcongresses.
700 10 $aFrench, Jacqueline A.
700 10 $aDichter, Marc A.
700 10 $aLeppik, Ilo E.